Doxycycline is an antibiotic used to treat bacterial infections such as acne, urinary tract infections, respiratory infections, and certain sexually transmitted infections. It works by killing bacteria or stopping their growth.[2] Vibramycin is currently approved and in use across 94 indications[4].[1]
Vibramycin is one of 1061 small molecule programs targeting Hailey-Hailey disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Patents
Pipeline
Competition
449 competitors in Non-Small Cell Lung Cancer
Vibramycin
Femara
HLX43
ABP 234
Remeron
Valemetostat Tosylate
Aqupla
Ftorafur
Treatment
PD-1 Inhibitors
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
VIBRAMYCIN
NDA NDA050006
Jan 1, 1982
VIBRAMYCIN
NDA NDA050480
Feb 10, 1992
MONODOX
NDA NDA050641
May 26, 2006
ORACEA
NDA NDA050805
Sources